Publication
Number of items: 11.
Article
Antithrombotic therapy in diabetes: Which, when, and for how long? (2021)
RA Ajjan,
N Kietsiriroje,
L Badimon,
Diana Gorog,
Dominick J. Angiolillo,
D Russel,
Bianca Rocca
and
Robert F. Storey
![]()
Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events : the RISK PPCI study. (2019)
Mohamed Farag,
Nikolaos Spinthakis,
Ying X. Gue,
Manivannan Srinivasan,
Keith Sullivan,
David Wellsted
and
Diana A. Gorog
![]()
Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters. (2024)
Diana A Gorog
![]()
Should we consider low LDL-cholesterol a marker of in-hospital bleeding in patients with acute coronary syndrome undergoing percutaneous coronary intervention? (2021)
Diana Gorog,
Eliano P Navarese
and
Felicita Andreotti
![]()
Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19. (2020)
Ying Gue
and
Diana Gorog
![]()
Prognostic impact of hypercoagulability and impaired fibrinolysis in acute myocardial infarction. (2023)
Seung Hun Lee,
Hyun Kuk Kim,
Jong-Hwa Ahn,
Min Gyu Kang,
Kye-Hwan Kim,
Jae Seok Bae,
Sang Young Cho,
Jin-Sin Koh,
Yongwhi Park,
Seok Jae Hwang,
Diana Gorog,
Udaya S. Tantry,
Kevin P. Bliden,
Paul A Gurbel,
Jin-Yong Hwang
and
Young-Hoon Jeong
![]()
Low-grade endotoxemia and platelets: a deadly aggregation. (2020)
Luca Liberale
and
Diana Gorog
![]()
Low-grade endotoxaemia and platelets : A deadly aggregation. (2020)
Luca Liberale
and
Diana A. Gorog
![]()
When a meta-analysis equals a single large-scale trial with meaningful follow-up. (2021)
Eliano P Navarese,
Dean Kereiakes,
Diana Gorog,
Alexandra Lansky
and
Felicita Andreotti
![]()
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: A systematic review and meta-analysis. (2021)
Eliano P Navarese,
Alexandra Lansky,
Dean Kereiakes,
Jacek Kubica,
Paul A Gurbel,
Diana Gorog,
Marco Valgimigli,
Nick Curzen,
David. E. Kandzari,
Marc Bonaca,
Marc Brouwer,
Julia M Umińska,
Milosz Jaguszewski,
Paolo Raggi,
Ron Waksman,
Martin B. Leon,
William Wijns
and
Felicita Andreotti
![]()
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes. (2020)
Robert F. Storey,
Paul A. Gurbel,
Jurrien ten Berg,
Corine Bernaud,
George D. Dangas,
Jean Marie Frenoux,
Diana A. Gorog,
Abdel Hmissi,
Vijay Kunadian,
Stefan K. James,
Jean Francois Tanguay,
Henry Tran,
Dietmar Trenk,
Mike Ufer,
Pim van der Harst,
Arnoud W.J. Van't Hof
and
Dominick J. Angiolillo
![]()